jim cramer on eli lilly's covid-19 phase 2 trial results for antibody drug
Published 4 years ago • 8.8K plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
11:27
jim cramer looks ahead to next week's market game plan
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
2:55
eli lilly's experimental obesity drug could be 'revolutionary,' says jim cramer
-
2:24
eli lilly may have developed the greatest drug of all time, says jim cramer
-
4:10
jim cramer: eli lilly pausing antibody trial isn't a big setback
-
4:12
'fast money' traders talk the upcoming slate of retail earnings
-
4:00
call of the day: tesla
-
2:04
cramer's mad dash: what could move apple higher than nvidia
-
3:48
eli lilly’s chief scientific officer on covid antibody drug results
-
3:32
jim cramer on how lilly's alzheimer's drug compares to biogen's
-
1:15
eli lilly starts late-stage trial for covid-19 antibody drug in nursing homes
-
0:41
jim cramer on the huge potential for eli lilly's answer to ozempic #shorts
-
2:49
jim cramer explains why he favors eli lilly in the weight loss drug space
-
2:44
jim cramer on how eli lilly could be impacted by mixed alzheimer's drug study results
-
2:39
eli lilly antibody drug reduces covid-19 risk in nursing homes: study
-
2:02
jim cramer explains why eli lilly will be the winner over biogen in alzheimer's fight
-
3:07
jim cramer: i remain very positive on eli lilly as the drug stock of the year
-
3:10
jim cramer's first take: eli lilly is a 'winner'
-
3:07
jim cramer: eli lilly stock represents real value
-
1:52
cramer’s mad dash: eli lilly
-
5:00
eli lilly pausing covid-19 trials is not a big deal: jefferies managing director
-
1:51
lilly drug cuts risk of contracting covid-19 by 80%: study